Key facts
- This page summarizes Everett Michael T.'s Form 4 filing for CALIX, INC (CALX).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 05 Dec 2022, 15:13.
Everett Michael T. - 02 Dec 2022 Form 4 Insider Report for CALIX, INC (CALX)
- Reporting relationship
- Director
- Issuer ticker
- CALX
- Reported as of
- 02 Dec 2022
- Net transaction value
- +$353,484
- SEC form
- 4
- Accepted by SEC
- 05 Dec 2022, 15:13:07 UTC
- Prior SEC filing
- 16 May 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tom Gemetti as Attorney-in-fact for Michael T Everett
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Everett Michael T. filed Form 4 for CALIX, INC (CALX) on 05 Dec 2022.
Change
- Previous filing in this sequence was filed on 16 May 2022.
- Current net transaction value: +$353,484.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CALX
transaction
Common Stock
Options Exercise
- Transaction value
- $353,484
- Shares
- +9,073
- Change %
- +4.8%
- Price
- $38.96
- Shares after
- 196,779
- Date
- 02 Dec 2022
- Ownership
- Direct
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CALX
transaction
Derivative
Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -9,073
- Change %
- -100%
- Price
- $0.000000*
- Shares after
- 0
- Date
- 02 Dec 2022
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 9,073
- Exercise price
- $38.96
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
100% of the shares subject to the option were fully vested and exercisable on May 13, 2022.